FDA approves Roche’s Actemra for the treatment of COVID-19 in hospitalised adults December 21, 2022January 20, 2023 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: U.S. FDA grants priority review to Roche’s…European Commission approves Roche’s Gavreto…CHMP recommends EU approval of Ronapreve to treat…Ronapreve approved by European Commission to treat…FDA grants priority review to Xolair (omalizumab)…CHMP recommends EU approval of Actemra/RoActemra to…
